Read
- Snowden threatens new U.S. leaks, asks numerous countries for asylum
- Egypt on the edge after Mursi rebuffs army ultimatum
|
- World shares rise, Europe dips on mixed growth outlook
- Taliban attack on supply base in Afghan capital kills six
- Documents show Milwaukee archdiocese shielded pedophile priests
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Gettysburg's 150th
Re-enactors and visitors mark the 150th anniversary of the Battle of Gettysburg, often described as the turning point of the Civil War. Slideshow
Gay pride parades
Revelers celebrate in gay pride parades around the world, on the heels of twin victories on same-sex marriage in the U.S. Supreme Court. Slideshow
Sponsored Links
FDA rejects Merck's insomnia drug
(Reuters) - Merck & Co Inc said the U.S. Food and Drug Administration rejected the company's experimental insomnia drug, citing safety issues.
In a complete response letter to the company, the FDA said the safety data of the drug do not support approval, and advised that lower doses of the medicine should be made available before an approval.
The efficacy of the drug, suvorexant, was established at doses of 10 mg to 40 mg in adults, the FDA said, adding that 10 mg should be the starting dose for most patients.
(Reporting by Esha Dey in Bangalore)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters